PHP Developer - Laravel, JavaScript - Manchester City Centre. 3 days in office, 2 days WFH... with collaboration at the heart. The PHP Developer's skills: PHP Laravel jQuery MySQL AWS Benefits: 20 days annual leave...
PHP Developer - Web Developer - Greater Manchester, Oldham Location: Oldham Salary: £35k + Benefits... Are you a talented PHP Laravel Developer looking for an exciting new opportunity? Join a dynamic development team in Oldham, Greater...
, AI or computer vision product development. ⛳️ Compensation, Perks & Benefits Php 100k - 140k per month depending on experience...: Php 1500 / month Wellness and learning allowance Onsite free lunch and snacks Inclusive and relaxed company culture...
America is trying to create a chip industry through isolation and protectionism, when what allowed it to emerge in Asia is the opposite: collaboration Continue Reading »
Stock market today: The Sensex ended 309 points, or 0.40 per cent, higher at 77,044.29, while the Nifty 50 settled at 23,437.20, up 109 points, or 0.47 per cent. Continue Reading »
Nifty 50 end 0.50% higher at 23,446 points, while the Sensex closed with a gain of 0.43% at 77,063 points. Broader markets continued to outperform frontline indices, with the Nifty Midcap 100 index ending the session 0.72% higher at 52,347 points, while the Nifty Smallcap 100 index rose 1.09%. Continue Reading »
Stock Market Today: Penny stock below Re 1 hits the upper circuit after dividend move. Sharanam Infraproject & Trading Ltd will consider dividend on 6 March. Details here Continue Reading »
As the Indian stock market faces potential volatility due to global macro headwinds, expert Avinash Pathak of LKP Securities highlights key sectors to watch and recommends seven stocks for long-term investment. Continue Reading »
IndiGo has gained analyst attention due to global expansion and favourable crude oil prices. With increased market share and new aircraft deliveries, brokerage firms have upgraded their ratings to 'buy', predicting continued growth in the Indian aviation market. Continue Reading »
Lupin Ltd. and Zydus Lifesciences Ltd. shares fell sharply after a US court upheld Astellas Pharma's patent on Myrbetriq, blocking the companies from selling their generic versions. This ruling poses significant challenges to their US market strategies and has raised investor concerns. Continue Reading »